↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
8 news outlets
policy
1 policy source
twitter
13 X users
patent
2 patents
guideline
1 clinical guideline source
podcasts
2 podcasts

Readers on

mendeley
208 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study
Published in
Journal for Immunotherapy of Cancer, January 2022
DOI 10.1136/jitc-2021-003777
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 208 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 208 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 18 9%
Student > Ph. D. Student 13 6%
Researcher 13 6%
Student > Master 11 5%
Student > Postgraduate 10 5%
Other 26 13%
Unknown 117 56%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 44 21%
Biochemistry, Genetics and Molecular Biology 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Nursing and Health Professions 3 1%
Immunology and Microbiology 3 1%
Other 15 7%
Unknown 125 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 91. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2026.
All research outputs
#594,060
of 34,329,910 outputs
Outputs from Journal for Immunotherapy of Cancer
#126
of 4,712 outputs
Outputs of similar age
#12,657
of 563,296 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#8
of 140 outputs
Altmetric has tracked 34,329,910 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,712 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 563,296 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.